The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians
Objectives: To determine if emergency physicians' (EP) use droperidol has changed since the United States Food and Drug Administration (FDA) warning of December 2001 concerning QT interval prolongation, torsade de pointes, and sudden death; and to query EP opinions regarding droperidol before a...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eScholarship Publishing, University of California
2003-01-01
|
Series: | Western Journal of Emergency Medicine |
Subjects: | |
Online Access: | http://escholarship.org/uc/item/0vh5m5rf |